These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10504820)

  • 21. A retrospective study of serum levels and electrocardiographic effects of nortriptyline in children and adolescents.
    Wilens TE; Biederman J; Spencer T; Geist DE
    J Am Acad Child Adolesc Psychiatry; 1993 Mar; 32(2):270-7. PubMed ID: 8444754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased use of clonidine following treatment with atomoxetine in children with ADHD.
    Johnston JA; Ye W; Van Brunt DL; Pohl G; Sumner CR
    J Clin Psychopharmacol; 2006 Aug; 26(4):389-95. PubMed ID: 16855457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of a guanfacine extended-release formulation in children and adolescents with attention-deficit-hyperactivity disorder.
    Boellner SW; Pennick M; Fiske K; Lyne A; Shojaei A
    Pharmacotherapy; 2007 Sep; 27(9):1253-62. PubMed ID: 17723079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapy of tic disorders apparently of organic origin in a multi-morbid 5-year-old patient with lofexidine (Britlofex) and clonidine (Catapressan)].
    Niederhofer H
    Wien Med Wochenschr; 2001; 151(13-14):327-8. PubMed ID: 11582998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Case study: adverse response to clonidine.
    Cantwell DP; Swanson J; Connor DF
    J Am Acad Child Adolesc Psychiatry; 1997 Apr; 36(4):539-44. PubMed ID: 9100429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
    Bricard C; Boidein F
    Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medications.
    Varley CK; Vincent J; Varley P; Calderon R
    Compr Psychiatry; 2001; 42(3):228-33. PubMed ID: 11349243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder.
    Winterstein AG; Gerhard T; Shuster J; Johnson M; Zito JM; Saidi A
    Pediatrics; 2007 Dec; 120(6):e1494-501. PubMed ID: 18055666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nortriptyline treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome.
    Spencer T; Biederman J; Wilens T; Steingard R; Geist D
    J Am Acad Child Adolesc Psychiatry; 1993 Jan; 32(1):205-10. PubMed ID: 8428873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attention-deficit/hyperactivity-related symptoms among children with enterovirus 71 infection of the central nervous system.
    Gau SS; Chang LY; Huang LM; Fan TY; Wu YY; Lin TY
    Pediatrics; 2008 Aug; 122(2):e452-8. PubMed ID: 18606624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.
    Polanczyk G; Zeni C; Genro JP; Guimarães AP; Roman T; Hutz MH; Rohde LA
    Arch Gen Psychiatry; 2007 Feb; 64(2):218-24. PubMed ID: 17283289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of perinatal adversities on tic severity and symptoms of attention deficit/hyperactivity disorder in children and adolescents with a tic disorder.
    Bos-Veneman NG; Kuin A; Minderaa RB; Hoekstra PJ
    J Dev Behav Pediatr; 2010; 31(2):100-6. PubMed ID: 20110829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Functioning, comorbidity and treatment of 141 adults with attention deficit hyperactivity disorder (ADHD) at a psychiatric outpatient department].
    Kooij JJ; Aeckerlin LP; Buitelaar JK
    Ned Tijdschr Geneeskd; 2001 Aug; 145(31):1498-501. PubMed ID: 11512422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized double-blind multicentre placebo-controlled clinical trial of the clonidine adhesive patch for the treatment of tic disorders.
    Du YS; Li HF; Vance A; Zhong YQ; Jiao FY; Wang HM; Wang MJ; Su LY; Yu DL; Ma SW; Wu JB
    Aust N Z J Psychiatry; 2008 Sep; 42(9):807-13. PubMed ID: 18696285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders.
    Allen AJ; Kurlan RM; Gilbert DL; Coffey BJ; Linder SL; Lewis DW; Winner PK; Dunn DW; Dure LS; Sallee FR; Milton DR; Mintz MI; Ricardi RK; Erenberg G; Layton LL; Feldman PD; Kelsey DK; Spencer TJ
    Neurology; 2005 Dec; 65(12):1941-9. PubMed ID: 16380617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ADHD treatment and academic performance: a case series.
    McCormick LH
    J Fam Pract; 2003 Aug; 52(8):620-4, 626. PubMed ID: 12899816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacologic treatment of attention deficit hyperactivity disorder.
    Greenhill LL
    Psychiatr Clin North Am; 1992 Mar; 15(1):1-27. PubMed ID: 1347936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychopharmacology of ADHD in adolescents.
    Greydanus DE; Sloane MA; Rappley MD
    Adolesc Med; 2002 Oct; 13(3):599-624. PubMed ID: 12270803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.